收费全文 | 1176篇 |
免费 | 62篇 |
国内免费 | 7篇 |
耳鼻咽喉 | 17篇 |
儿科学 | 12篇 |
妇产科学 | 42篇 |
基础医学 | 81篇 |
口腔科学 | 31篇 |
临床医学 | 80篇 |
内科学 | 261篇 |
皮肤病学 | 12篇 |
神经病学 | 71篇 |
特种医学 | 31篇 |
外科学 | 416篇 |
综合类 | 5篇 |
预防医学 | 47篇 |
眼科学 | 30篇 |
药学 | 29篇 |
中国医学 | 1篇 |
肿瘤学 | 79篇 |
2024年 | 1篇 |
2023年 | 21篇 |
2022年 | 31篇 |
2021年 | 61篇 |
2020年 | 38篇 |
2019年 | 37篇 |
2018年 | 49篇 |
2017年 | 37篇 |
2016年 | 47篇 |
2015年 | 54篇 |
2014年 | 93篇 |
2013年 | 86篇 |
2012年 | 93篇 |
2011年 | 111篇 |
2010年 | 63篇 |
2009年 | 61篇 |
2008年 | 62篇 |
2007年 | 68篇 |
2006年 | 28篇 |
2005年 | 33篇 |
2004年 | 27篇 |
2003年 | 18篇 |
2002年 | 21篇 |
2001年 | 14篇 |
2000年 | 15篇 |
1999年 | 17篇 |
1998年 | 3篇 |
1997年 | 1篇 |
1996年 | 1篇 |
1994年 | 1篇 |
1993年 | 4篇 |
1992年 | 8篇 |
1991年 | 6篇 |
1990年 | 5篇 |
1989年 | 2篇 |
1988年 | 6篇 |
1987年 | 3篇 |
1986年 | 1篇 |
1985年 | 2篇 |
1984年 | 3篇 |
1983年 | 1篇 |
1981年 | 1篇 |
1980年 | 2篇 |
1979年 | 5篇 |
1978年 | 1篇 |
1976年 | 1篇 |
1970年 | 1篇 |
1966年 | 1篇 |
To describe certain anatomical variations of the foramen transversarium, in spine cervical vertebrae in a contemporary specimen of an Indo-European population and approach their clinical importance during cervical spine surgery.
Methods102 cervical vertebrae (C2–C7) from 17 different skeletons, intact without any degenerative or traumatic disorders, which belonged to the collection of the Department of Anatomy, were examined. The age of specimens at the time of their death was between 25 and 65 years. All foramina were measured with a digital caliper.
ResultsThe average size of the normal foramina was: 6.49 mm × 5.74 mm on the right side and 6.65 mm × 5.76 mm on the left side. Regarding the variations, we found two cervical vertebrae (1.96 %), one C3 and one C6, in which the right foramen transversarium is clearly smaller than the left. The exact dimensions of these foramina are: 2.3 mm × 2.5 mm on the right side and 6.54 mm × 8 mm on the left side in the first vertebra and 2.8 mm × 3.74 mm on the right side and 6 mm × 7.5 mm on the left side, in the second one. We also observed double foramina in 14 vertebrae (13.72 %). In seven vertebrae, the duplication was bilateral (6.86 %). We finally found one vertebra (0.98 %) with triplication of the foramen transversarium on the left side.
ConclusionsSummarizing, 10 out of our 17 skeletons were presented with variations (extremely narrow or multiple foramina). This finding of hypoplastic, duplicated and triplicated foramina transversaria in unexpectedly high rates raises questions about the integrity of the contained structures, the possibility of a different path for them. These variations may induce an extra-osseous position of the vertebra artery, and the ignorance of such an event may have catastrophic consequences during a surgery in the cervical spine.
相似文献Scientific data regarding intravenous iron supplementation in peritoneal dialysis (PD) patients are scarce. In attempting to administer the minimum monthly IV iron dose that could improve erythropoiesis, we wanted to assess the safety and efficacy of monthly maintenance intravenous administration of 100 mg iron sucrose in PD patients.
MethodsIn a 9-month prospective study, all clinically stable PD patients received intravenously 200 mg of iron sucrose as a loading dose, followed by monthly doses of 100 mg for five consecutive months. Levels of hemoglobin (Hb), ferritin, transferrin saturation (TSAT), reticulocyte hemoglobin content (CHr) and C-reactive protein (CRP) were measured before each administration and 3 months after the last iron infusion. Also, doses of concurrent erythropoietin administration were recorded.
ResultsEighteen patients were eligible for the study. Mean levels of Hb and ferritin increased significantly (from 10.0 to 10.9 mg/dL, p?=?0.01 and from 143 to 260 ng/mL, p?=?0.005), as well as the increase in TSAT levels approached borderline significance (from 26.2 to 33.1%, p?=?0.07). During the 6 months of iron administration, the erythropoietin dose was reduced in five patients and discontinued in one. During the 3 months following the last iron infusion, three of them again raised the erythropoietin dose to previous levels. None of the patients experienced any side effects related to IV iron administration.
ConclusionsA monthly maintenance intravenous dose of 100 mg iron sucrose may be a practical, effective, and safe in the short term, treatment of anemia in PD patients resulting in improved hemoglobin levels, iron indices, and erythropoietin response.
相似文献